These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 13064031)

  • 41. Further observations on the effects of autonomic blocking agents in patients with hypertension. I. General systemic effects of hexamethonium, pentamethonium, and hydrazinophthalazine.
    GROB D; LANGFORD HG
    Circulation; 1953 Aug; 8(2):20. PubMed ID: 13067201
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of hexemethonium chloride and 1-hydrazinophthalazine in the treatment of hypertension.
    LINLEY DM; ESKWITH IS
    Conn State Med J; 1953 Jun; 17(6):498-500. PubMed ID: 13060020
    [No Abstract]   [Full Text] [Related]  

  • 43. The treatment of hypertension with hexamethonium and hydrazinophthalazine (apresoline).
    CUBBERLY RB; WIESEL LL; LAMB AE
    Brooklyn Hosp J; 1953; 11(3 3rd Quarter):125-34. PubMed ID: 13094157
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of hypertension with hydrazinophthalazines with special reference to combined therapy].
    BRICHTA G; FALKNER R; NEUMAYR A; WEISSEL W
    Wien Z Inn Med; 1953; 34(7-8):283-92. PubMed ID: 13103081
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of hypertension with hexamethonium alone and in combination with apresoline.
    MILLER SI; LIVESAY WR; SNYDER HB; MOYER JH
    Tex State J Med; 1953 Jul; 49(7):516-22. PubMed ID: 13077420
    [No Abstract]   [Full Text] [Related]  

  • 46. [The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine].
    PAGE I; TAYLOR RD; CORCORAN AC
    Medizinische; 1952 Nov; 20(48):1516-8. PubMed ID: 13024596
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical experience with a new combination of hypotensive agents.
    SMITH CW; QUICKEL KE; BROWN AE; THOMAS CG
    Am J Med Sci; 1955 Oct; 230(4):415-25. PubMed ID: 13258573
    [No Abstract]   [Full Text] [Related]  

  • 48. A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.
    FREIS ED; PARTENOPE EA; LILIENFIELD LS; ROSE JC
    Circulation; 1954 Apr; 9(4):540-6. PubMed ID: 13150518
    [No Abstract]   [Full Text] [Related]  

  • 49. Newer drugs in the treatment of hypertension. II. Use of hexamethonium in combination with hydralazine.
    RAST CL; ORGAIN ES; MULLER JC; PRYOR WW; SIEBER HA
    Circulation; 1955 Sep; 12(3):361-9. PubMed ID: 13250698
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of hypertension. I. Modifications of arterial pressure].
    TAQUINI AC; CAPRIS TA; PLESCH SA
    Prensa Med Argent; 1955 Jul; 42(27):2006-10. PubMed ID: 13273284
    [No Abstract]   [Full Text] [Related]  

  • 51. The drug treatment of severe hypertensive disease, with particular reference to hydralazine and pentapyrrolidinium.
    HOOBLER SW
    Trans Am Coll Cardiol; 1955 Dec; 5():101-6. PubMed ID: 13274398
    [No Abstract]   [Full Text] [Related]  

  • 52. Essential hypertension; treatment with hexamethonium and apresoline.
    SHAPERA RP; LANG FR
    U S Armed Forces Med J; 1953 Jun; 4(6):903-6. PubMed ID: 13049707
    [No Abstract]   [Full Text] [Related]  

  • 53. Hexamethonium and apresoline (1-hydrazinophthalazine).
    KVALE WF
    Proc Staff Meet Mayo Clin; 1952 Nov; 27(24):489-94. PubMed ID: 13004022
    [No Abstract]   [Full Text] [Related]  

  • 54. Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
    STEEVES LC; SHEARS AH; SPELLER SL
    Treat Serv Bull; 1953 Oct; 8(9):573-8. PubMed ID: 13102592
    [No Abstract]   [Full Text] [Related]  

  • 55. The control of arterial hypertension by hyphex, with an evaluation of other methods of therapy.
    SCHROEDER HA; MORROW JD
    Med Clin North Am; 1953 Jul; 1(Nationwide Number):991-1008. PubMed ID: 13062842
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical evaluation of hydralazine (apresoline) alone and in combination with veriloid in the treatment of hypertension.
    KERT MJ; ROSENFELD S; MAILMAN RH; WESTERGART JP; CARLETON HG; HISCOCK E
    Angiology; 1954 Aug; 5(4):318-28. PubMed ID: 13181012
    [No Abstract]   [Full Text] [Related]  

  • 57. A preliminary report on clinical experiences with hexamethonium and 1-hydrazinophthalazine in the treatment of diastolic hypertension.
    ROMNEY RB; BULLINGTON RH; ABILDSKOV JA; RAY CT; BURCH GE
    J La State Med Soc; 1953 Apr; 105(4):153-7. PubMed ID: 13053045
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the control of hypertension by hyphex. V. Effects on the course of the malignant stage.
    SCHROEDER HA; MORROW JD; PERRY HM
    Circulation; 1954 Sep; 10(3):321-30. PubMed ID: 13190604
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical use of hydralazine and hexamethonium in treatment of hypertension.
    HILKER RR; RHOADS PS; BILLINGS CE
    J Am Med Assoc; 1953 Sep; 153(1):5-9. PubMed ID: 13069256
    [No Abstract]   [Full Text] [Related]  

  • 60. Practical drug treatment of migraine headache.
    OATMAN JG
    Antibiotic Med Clin Ther (New York); 1956 Dec; 3(7):439-45. PubMed ID: 13373311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.